Enhanced RBC Aggregation in Type 2 Diabetes Patients

被引:19
作者
Li, Qing [1 ]
Li, Li [2 ]
Li, Yong [1 ]
机构
[1] Shanghai Ctr Clin Lab, Shanghai, Peoples R China
[2] Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China
关键词
erythrocyte sedimentation rate; RBC aggregation; HbA(1c); T2DM; BLOOD-CELL AGGREGATION; ERYTHROCYTE AGGREGATION; GLYCOSYLATED HEMOGLOBIN; SEDIMENTATION-RATE; MELLITUS;
D O I
10.1002/jcla.21784
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: This study aimed to investigate the relationship between HbA(1c) and RBC aggregation in type 2 diabetes mellitus (T2DM) patients by analysis of data from routine clinical tests and from in vitro experiments. Methods: A total of 2,111 inpatients with type 2 diabetes were selected and among them, 364 patients (Group A) had limited influence of plasma proteins on erythrocyte sedimentation rate (ESR) and was compared with the rest of the 1,747 inpatients (Group B). ESR, HbA(1c), WBC, CRP, Fbg, and HCT were measured in all samples. Sixty samples were also collected from T2DM patients and used for in vitro ESR studies. Spearman's correlation coefficients were employed to reflect the correlation between ESR and other parameters. Mann-Whitney U test was used to compare the study parameters. Results: The test results for Group A were lower than Group B with respect to ESR, age, HCT, HbA(1c), CRP, WBC, and Fbg. Only the difference in HbA(1c), CRP, and Fbg values had statistical significance (P < 0.05). In addition, HbA(1c) correlated better with ESR for Group A (R = 0.622) than Group B (R = 0.563), whereas CRP and Fbg were contrary to this. In the in vitro studies, the HbA(1c) values were classified into the subgroups of 6.5-8.0%, 8.1-10%, and > 10%. The corresponding ESR values were 28 +/- 5.1 mm/h, 33 +/- 2.7 mm/h, and 40 +/- 4.1 mm/h, respectively. Conclusion: ESR results of T2DM patients were elevated that was mainly caused by Fbg levels, and in addition HbA(1c) in part contributed to RBC aggregation. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:387 / 389
页数:3
相关论文
共 18 条
  • [1] BAUERSACHS RM, 1989, CLIN HEMORHEOL, V9, P935
  • [2] Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus
    Chong-Martinez, B
    Buchanan, TA
    Wenby, RB
    Meiselman, HJ
    [J]. DIABETIC MEDICINE, 2003, 20 (04) : 301 - 306
  • [3] Enhanced erythrocyte aggregation in type 2 diabetes with late complications
    Demiroglu, H
    Gürlek, A
    Barista, I
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 (01) : 35 - 39
  • [4] Effect of Atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients
    Dujovne, CA
    Harris, WS
    Altman, R
    Overhiser, RW
    Black, DM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (03) : 350 - 353
  • [5] ELIAS AN, 1989, J MED, V20, P297
  • [6] Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control
    Elishkevitz, K
    Fusman, R
    Koffler, M
    Shapira, I
    Zeltser, D
    Avitzour, D
    Arber, N
    Berliner, S
    Rotstein, R
    [J]. DIABETIC MEDICINE, 2002, 19 (02) : 152 - 156
  • [7] Inflammatory activity increases with haemoglobin A1c in patients with acute coronary syndrome
    Gustavsson, Carl Gunnar
    Agardh, Carl-David
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2009, 43 (06) : 380 - 385
  • [8] Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range
    Gustavsson, CG
    Agardh, CD
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (23) : 2120 - 2124
  • [9] ICSH review of the measurement of the erythocyte sedimentation rate
    Jou, J. M.
    Lewis, S. M.
    Briggs, C.
    Lee, S. -H.
    De la Salle, B.
    McFadden, S.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2011, 33 (02) : 125 - 132
  • [10] Kameneva MV, 1998, CLIN HEMORHEOL MICRO, V18, P67